google.com, pub-9020093427036192, DIRECT, f08c47fec0942fa0

Mesothelioma Immunotherapy 2026: Opdivo, Keytruda & Latest Breakthroughs

Mesothelioma immunotherapy 2026 guide covering Opdivo nivolumab Keytruda pembrolizumab treatments, survival rates, eligibility and latest breakthroughs for patients

📅 Updated: April 2026 | ⏱ 14-minute read | ✅ Medically & Legally Reviewed Introduction In October 2020, the FDA approved nivolumab + ipilimumab (Opdivo + Yervoy) for mesothelioma, the first new treatment approval for this disease in 16 years. It was not a modest advance. The CheckMate 743 trial that supported that approval showed … Read more

Mesothelioma Clinical Trials 2026: New Treatments & How to Join

Mesothelioma clinical trials 2026 guide covering new immunotherapy treatments, eligibility requirements, how to join and compensation available for patients and families

📅 Updated: April 2026 | ⏱ 13-minute read | ✅ Medically & Legally Reviewed Introduction Mesothelioma Clinical Trials 2026 In 2020, the FDA approved the first new mesothelioma treatment in 16 years. In 2024, ASCO updated its mesothelioma treatment guidelines for the first time since 2018. In March 2026, five-year data from the landmark CheckMate … Read more